drugset / Trial / NCT02957097

Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

NCT02957097 ↗

Phase 4 Withdrawn Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of pre-operative administration of gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and maxillofacial surgical procedures.

Timeline

Start
2019-09
Primary completion
2021-06
Completion
2021-07

Outcome

Outcome not reported

Stopped: “Original PI left institution and the PI who took over was not able to initiate the study so it was never started.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 900 mg Oral